Ampersand Capital Partners' Melanie Fan And Hidde Van Kerckhoven Recognized By Growthcap As 2025 Top 40 Under 40 Growth Investors

(MENAFN- GlobeNewsWire - Nasdaq) Boston, MA, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Ampersand Capital Partners is pleased to announce that Melanie Fan and Hidde Van Kerckhoven have been named to GrowthCap's Top 40 Under 40 Growth Investors of 2025. This prestigious recognition honors the next generation of leaders shaping the future of growth equity investing. Melanie's and Hidde's inclusion reflects their impact across Ampersand's life sciences and healthcare-focused investment strategy and their continued commitment to supporting innovation, operational excellence, and growth within the firm's portfolio.

GrowthCap's Top 40 Under 40 program highlights exceptional investors who have distinguished themselves through disciplined investment judgment, strong partnership with management teams, and a focus on long-term value creation. The 2025 honorees were recognized for their ability to navigate an evolving investment landscape marked by rapid technological change, increased attention to operational excellence, and heightened complexity across global markets. GrowthCap noted that investors in 2025 operated with a more disciplined mindset while maintaining a strong focus on fundamentals and sustainable value creation.

To see the full list of honorees and to learn more about the selection criteria and methodology, please visit the GrowthCap website.

Disclaimer: This award was provided by GrowthCap on January 7, 2026 and was based on the time period since inception of each individual's career at Ampersand through November 19, 2025. Ampersand submitted nominations to be considered for the GrowthCap Top 40 Under 40 Growth Investors list and, once selected by GrowthCap as an honoree, Ampersand paid a publishing and copyright fee to GrowthCap to promote this award. The data provided in this award publication is for informational purposes only and should not be construed as investment advice, endorsement, nor recommendation. GrowthCap believes the information in this publication to be accurate but does not verify its accuracy independently and does not warrant or guarantee that it is accurate or complete. GrowthCap has no obligation to provide any updates or changes to the information. No investment decisions should be made using this information.

About Ampersand Capital Partners

Ampersand Capital Partners, founded in 1988, is a middle-market private equity firm with $3 billion of assets under management, dedicated to growth-oriented investments in the healthcare sector. With hubs in Boston, Amsterdam, and London, Ampersand leverages a unique blend of private equity and operating experience to build value and drive long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous market-leading companies across each of the firm's core healthcare sectors. For additional information, visit or follow us on LinkedIn.

Attachment

• Ampersand Capital Partners

CONTACT: Kathleen Toomey Ampersand Capital Partners...

MENAFN07012026004107003653ID1110568023